Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges

BenzingaOct 2 10:37 ET

Bristol-Myers Tops Growth Chart Among S&P 500 Healthcare Stocks in Q3

Seeking AlphaOct 2 10:07 ET

Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn't a Problem. -- Barrons.com

Barron'sOct 2 09:48 ET · Ratings

Eli Lilly (NYSE:LLY) Eyes Broader Market for Weight-Loss Drugs

TipRanksOct 2 09:36 ET

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

24/7 Wall St.Oct 2 08:16 ET

Express News | Eli Lilly and Co - Medicine Foundry Expected to Add 400 Full-Time Jobs

ReutersOct 2 07:30 ET